CDK9 inhibition sensitizes intrinsically resistant BRAFV600E mutant colorectal cancer to BRAF inhibitors
Acta Pharmaceutica Sinica B · 2026-08 · 16 (8) · 5131-5147
DOI: 10.1016/j.apsb.2026.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-08. Verfasst von Ning Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Montefiore Einstein Comprehensive Cancer Center, Cancer Therapeutics Program, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Montefiore Einstein Comprehensive Cancer Center, Cancer Therapeutics Program, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- University of Texas MD Anderson Cancer Center
- National Institutes of Health
- NCI
Zitieren
APA
Wei, N., Thielen, N., Mohammadi, M., Bhat, M. A., Li, T., Sun, Y., Kitamura, S., Chu, E., & Kuang, C. (2026). CDK9 inhibition sensitizes intrinsically resistant BRAFV600E mutant colorectal cancer to BRAF inhibitors. Acta Pharmaceutica Sinica B, 16(8), 5131-5147. https://doi.org/10.1016/j.apsb.2026.05.008
Vancouver
Wei N, Thielen N, Mohammadi M, Bhat MA, Li T, Sun Y, et al. CDK9 inhibition sensitizes intrinsically resistant BRAFV600E mutant colorectal cancer to BRAF inhibitors. Acta Pharmaceutica Sinica B. 2026;16(8):5131-5147. doi:10.1016/j.apsb.2026.05.008
BibTeX
@article{Wei2026,
author = {Wei, Ning and Thielen, Natalie and Mohammadi, Mahshid and Bhat, Muzaffer Ahmed and Li, Terence and Sun, Yan and Kitamura, Seiya and Chu, Edward and Kuang, Chaoyuan},
title = {CDK9 inhibition sensitizes intrinsically resistant BRAFV600E mutant colorectal cancer to BRAF inhibitors},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {8},
pages = {5131--5147},
doi = {10.1016/j.apsb.2026.05.008}
}
EUVIMED